Venous thromboembolism and prognosis in cancer.

[1]  C. Francis,et al.  Impact of venous thromboembolism and anticoagulation on cancer and cancer survival. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  H. Chew,et al.  Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. , 2009, Blood.

[3]  A. Khorana,et al.  Venous Thromboembolism Risk Model Predicts Early Progression and Overall Mortality in Cancer Patients Receiving Chemotherapy , 2008 .

[4]  J. Sehouli,et al.  Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. , 2008, Journal of Clinical Oncology.

[5]  A. Khorana,et al.  Venous thromboembolism and all-cause mortality in cancer patients receiving chemotherapy , 2008 .

[6]  Gary H Lyman,et al.  Development and validation of a predictive model for chemotherapy-associated thrombosis. , 2008, Blood.

[7]  H. Chew,et al.  The incidence of venous thromboembolism among patients with primary lung cancer , 2008, Journal of thrombosis and haemostasis : JTH.

[8]  Miriam Lopez Gomez,et al.  Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients , 2008, Cancer.

[9]  B. Barlogie,et al.  Effect on survival of treatment-associated venous thromboembolism in newly diagnosed multiple myeloma patients , 2007, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[10]  A. Khorana,et al.  Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy , 2007, Journal of thrombosis and haemostasis : JTH.

[11]  H. Chew,et al.  Incidence of venous thromboembolism and the impact on survival in breast cancer patients. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  C. Gross,et al.  The Impact of Venous Thromboembolism on Risk of Death or Hemorrhage in Older Cancer Patients , 2007, Journal of General Internal Medicine.

[13]  H. Chew,et al.  Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  H. Chew,et al.  Incidence of venous thromboembolism and its effect on survival among patients with common cancers. , 2006, Archives of internal medicine.

[15]  Liz Y. Han,et al.  Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  R. Fisher,et al.  Thromboembolism in hospitalized neutropenic cancer patients. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  R. Fisher,et al.  Venous thromboembolism in patients with diffuse large B-cell lymphoma , 2006, Leukemia & lymphoma.

[18]  S. Hirohashi,et al.  Prognostic Significance of Tissue Factor in Pancreatic Ductal Adenocarcinoma , 2005, Clinical Cancer Research.

[19]  A. Khorana.  Malignancy, thrombosis and Trousseau: the case for an eponym , 2003, Journal of thrombosis and haemostasis : JTH.

[20]  Steven Patierno,et al.  Tissue factor, thrombin, and cancer. , 2003, Chest.

[21]  Bart Barlogie,et al.  Thalidomide and deep vein thrombosis in multiple myeloma: risk factors and effect on survival. , 2003, Clinical lymphoma.

[22]  J. Berkhof,et al.  Potential role of platelets in endothelial damage observed during treatment with cisplatin, gemcitabine, and the angiogenesis inhibitor SU5416. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  F. Kabbinavar,et al.  Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  G. Lip,et al.  The hypercoagulable state of malignancy: pathogenesis and current debate. , 2002, Neoplasia.

[25]  M. Baccarani,et al.  Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy. , 2002, Blood.

[26]  L. Melton,et al.  Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. , 2002, Archives of internal medicine.

[27]  J. Olsen,et al.  Prognosis of cancers associated with venous thromboembolism. , 2000, The New England journal of medicine.

[28]  J. Folkman,et al.  The Hemostatic System as a Regulator of Angiogenesis* , 2000, The Journal of Biological Chemistry.